Literature DB >> 32199055

Congenital heart disease, prenatal diagnosis and management.

César H Meller1, Sofía Grinenco2, Horacio Aiello3, Antonela Córdoba2, María M Sáenz-Tejeira2, Pablo Marantz3, Lucas Otaño3.   

Abstract

Among congenital malformations, heart defects are the most common type of anomaly, and these are associated with a high perinatal, longterm morbidity and mortality. The objective of this update was to review the rate of prenatal detection, screening characteristics throughout the pregnancy, in both the first and second trimesters, indications for advanced echocardiography, and to establish a management algorithm in case of prenatal diagnosis of a congenital heart disease. Potential invasive and non-invasive tests and obstetric follow-up will be discussed here. Finally, the main characteristics of fetal therapy in heart anomalies will be reviewed, both cardiac interventions and intrauterine treatment of arrhythmias. Sociedad Argentina de Pediatría.

Entities:  

Keywords:  congenital heart disease; fetal therapy; prenatal diagnosis; screening

Mesh:

Year:  2020        PMID: 32199055     DOI: 10.5546/aap.2020.eng.e149

Source DB:  PubMed          Journal:  Arch Argent Pediatr        ISSN: 0325-0075            Impact factor:   0.635


  9 in total

1.  Association of the levels of heavy metals and trace elements during pregnancy with congenital heart defects in offspring: a prospective cohort study.

Authors:  Jing-Ting Liu; Ya-Wei Zhou; Wen-Di Wang; Bao-Hong Mao; Ya-Guang Hu
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-02-15

2.  Diagnosis and Challenges in Perinatal Health.

Authors:  Blanca Riquelme-Gallego; Rafael A Caparros-Gonzalez
Journal:  Diagnostics (Basel)       Date:  2022-06-06

3.  Utility of Screening Fetal Echocardiogram Following Normal Anatomy Ultrasound for In Vitro Fertilization Pregnancies.

Authors:  Rebecca R Spurr; Jeffrey A Conwell; Luciana T Young; Mark B Lewin; Lindsay A Edwards; Bhawna Arya
Journal:  Pediatr Cardiol       Date:  2022-02-26       Impact factor: 1.838

Review 4.  Identification of differential microRNAs and messenger RNAs resulting from ASXL transcriptional regulator 3 knockdown during during heart development.

Authors:  Ze-Qun Liu; Mi Cheng; Fang Fu; Ru Li; Jin Han; Xin Yang; Qiong Deng; Lu-Shan Li; Ting-Ying Lei; Dong-Zhi Li; Can Liao
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

5.  Role of routine fetal echocardiography in an unselected group of pregnant women for prenatal detection of cardiac malformations.

Authors:  Anupam Bhambhani; Amalu Mathew; Mary Varunya; Seema Uligada; Prachi Kala
Journal:  Indian Heart J       Date:  2020-08-13

6.  SNP Array as a Tool for Prenatal Diagnosis of Congenital Heart Disease Screened by Echocardiography: Implications for Precision Assessment of Fetal Prognosis.

Authors:  Hailong Huang; Meiying Cai; Yan Wang; Bin Liang; Na Lin; Liangpu Xu
Journal:  Risk Manag Healthc Policy       Date:  2021-01-27

7.  Risk Assessment of the Increased Occurrence of Congenital Cardiac and Non-Cardiac Defects in Fetuses with a Normal Karyotype after Assisted Fertilization in Comparison to Natural Fertilization Based on Ultrasound Diagnostics.

Authors:  Dawid Serafin; Beniamin Oskar Grabarek; Dariusz Boroń; Andrzej Madej; Bartosz Czuba
Journal:  J Clin Med       Date:  2021-11-29       Impact factor: 4.241

8.  Circular RNA hsa_circ_105039 promotes cardiomyocyte differentiation by sponging miR‑17 to regulate cyclinD2 expression.

Authors:  Boshi Yu; Mengmeng Li; Shu Ping Han; Zhangbin Yu; Jingai Zhu
Journal:  Mol Med Rep       Date:  2021-10-19       Impact factor: 2.952

9.  Vigilance in the Decision-Making Process Regarding Termination of Pregnancy Following Prenatal Diagnosis of Congenital Heart Disease-Application of the 'Conflict Decision-Making Model'.

Authors:  Yulia Gendler; Einat Birk; Nili Tabak; Silvia Koton
Journal:  Int J Environ Res Public Health       Date:  2022-07-26       Impact factor: 4.614

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.